NCT04499352View on ClinicalTrials.gov

A Study to Test BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal Cancer

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 14, 2020

Primary Completion Date

October 19, 2020

Study Completion Date

October 19, 2020

Conditions
Anal Canal Squamous Cell Carcinoma
Interventions
DRUG

BI 754091

BI 754091

DRUG

BI 836880

BI 836880

Trial Locations (1)

05505

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04499352 - A Study to Test BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal Cancer | Biotech Hunter | Biotech Hunter